These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22168943)

  • 1. [Retros Flt-1 decelerates the growth of a murine experimental osteosarcoma].
    Xin XT; Yin DZ; Lan H; Chen C; Liu B; Yang SY
    Zhonghua Wai Ke Za Zhi; 2011 Aug; 49(8):746-51. PubMed ID: 22168943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF blockade decelerates the growth of a murine experimental osteosarcoma.
    Yin D; Jia T; Gong W; Yu H; Wooley PH; Mott MP; Yang SY
    Int J Oncol; 2008 Aug; 33(2):253-9. PubMed ID: 18636145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
    Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity.
    Mahasreshti PJ; Kataram M; Wang MH; Stockard CR; Grizzle WE; Carey D; Siegal GP; Haisma HJ; Alvarez RD; Curiel DT
    Clin Cancer Res; 2003 Jul; 9(7):2701-10. PubMed ID: 12855650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor and soluble FLT-1 receptor interactions and biological implications.
    Malecki M; Trembacz H; Szaniawska B; Przybyszewska M; Janik P
    Oncol Rep; 2005 Dec; 14(6):1565-9. PubMed ID: 16273257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
    Park HR; Min K; Kim HS; Jung WW; Park YK
    Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer.
    Hasumi Y; Mizukami H; Urabe M; Kohno T; Takeuchi K; Kume A; Momoeda M; Yoshikawa H; Tsuruo T; Shibuya M; Taketani Y; Ozawa K
    Cancer Res; 2002 Apr; 62(7):2019-23. PubMed ID: 11929819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment modifications induced by soluble VEGF receptor expression in a rat liver metastasis model.
    Bertin S; Mohsen-Kanson T; Baqué P; Gavelli A; Momier D; Anjuere F; Carle GF; Pierrefite-Carle V
    Cancer Lett; 2010 Dec; 298(2):264-72. PubMed ID: 20702033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma.
    Mahasreshti PJ; Navarro JG; Kataram M; Wang MH; Carey D; Siegal GP; Barnes MN; Nettelbeck DM; Alvarez RD; Hemminki A; Curiel DT
    Clin Cancer Res; 2001 Jul; 7(7):2057-66. PubMed ID: 11448924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Flt-1 gene transfer ameliorates neointima formation after wire injury in flt-1 tyrosine kinase-deficient mice.
    Koga J; Matoba T; Egashira K; Kubo M; Miyagawa M; Iwata E; Sueishi K; Shibuya M; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):458-64. PubMed ID: 19164801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma.
    Tzeng HE; Tsai CH; Chang ZL; Su CM; Wang SW; Hwang WL; Tang CH
    Biochem Pharmacol; 2013 Feb; 85(4):531-40. PubMed ID: 23219526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flt-1 signaling in macrophages promotes glioma growth in vivo.
    Kerber M; Reiss Y; Wickersheim A; Jugold M; Kiessling F; Heil M; Tchaikovski V; Waltenberger J; Shibuya M; Plate KH; Machein MR
    Cancer Res; 2008 Sep; 68(18):7342-51. PubMed ID: 18794121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine VEGF/VEGFR1 signaling in a subpopulation of cells associates with aggressive osteosarcoma.
    Ohba T; Cates JM; Cole HA; Slosky DA; Haro H; Ando T; Schwartz HS; Schoenecker JG
    Mol Cancer Res; 2014 Aug; 12(8):1100-11. PubMed ID: 24759089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
    Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
    Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of marrow-derived endothelial cells to experimental choroidal neovascularization by local expression of vascular endothelial growth factor.
    Csaky KG; Baffi JZ; Byrnes GA; Wolfe JD; Hilmer SC; Flippin J; Cousins SW
    Exp Eye Res; 2004 Jun; 78(6):1107-16. PubMed ID: 15109917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.
    Zhang Z; Zou W; Wang J; Gu J; Dang Y; Li B; Zhao L; Qian C; Qian Q; Liu X
    Mol Ther; 2005 Apr; 11(4):553-62. PubMed ID: 15771958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of soluble vascular endothelial growth factor (VEGF) receptor gene (sflt-1) and antisense VEGF nucleotide on neovascularization].
    Mi J; Wang JH; Chen SS
    Ai Zheng; 2002 May; 21(5):464-8. PubMed ID: 12452033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LacZ transgene expression in the subcutaneous Dunn/LM8 osteosarcoma mouse model allows for the identification of micrometastasis.
    Arlt MJ; Banke IJ; Walters DK; Puskas GJ; Steinmann P; Muff R; Born W; Fuchs B
    J Orthop Res; 2011 Jun; 29(6):938-46. PubMed ID: 21284029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paracrine action of sFLT-1 secreted by stably-transfected Ehrlich ascites tumor cells and therapy using sFLT-1 inhibits ascites tumor growth in vivo.
    Ramachandra S; D'Souza SS; Gururaj AE; Shaila MS; Salimath BP
    J Gene Med; 2009 May; 11(5):422-34. PubMed ID: 19266483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice.
    Davidoff AM; Ng CY; Brown P; Leary MA; Spurbeck WW; Zhou J; Horwitz E; Vanin EF; Nienhuis AW
    Clin Cancer Res; 2001 Sep; 7(9):2870-9. PubMed ID: 11555605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.